LI
Lafayette Investments Portfolio holdings
AUM
$495M
This Quarter Return
+11.68%
1 Year Return
+21.02%
3 Year Return
+72.03%
5 Year Return
+143.59%
10 Year Return
+235.5%
AUM
$445M
AUM Growth
+$42.7M
(+11%)
Cap. Flow
-$89.6K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
42.84%
Holding
144
New
9
Increased
53
Reduced
46
Closed
3
Top Buys
| 1 |
Starbucks
SBUX
|
$557K |
| 2 |
Booking.com
BKNG
|
$385K |
| 3 |
McDonald's
MCD
|
$305K |
| 4 |
Texas Instruments
TXN
|
$298K |
| 5 |
Eli Lilly
LLY
|
$253K |
Top Sells
| 1 |
Enovis
ENOV
|
$1.67M |
| 2 |
Madison Square Garden
MSGS
|
$717K |
| 3 |
Meta Platforms (Facebook)
META
|
$545K |
| 4 |
Lennox International
LII
|
$453K |
| 5 |
Spotify
SPOT
|
$428K |
Sector Composition
| 1 | Financials | 36.04% |
| 2 | Technology | 16.89% |
| 3 | Consumer Discretionary | 11.69% |
| 4 | Industrials | 11.48% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Federal Realty Investment Trust
FRT
$8.63B
| $220K | 0.05% |
2,150
| – | – |
|
127
Zoetis
ZTS
$67.6B
| $218K | 0.05% |
1,287
+260
| +25% | +$44K |
|
128
lululemon athletica
LULU
$23.8B
| $216K | 0.05% |
554
+141
| +34% | +$55.1K |
|
129
Intuit
INTU
$187B
| $216K | 0.05% |
332
+2
| +0.6% | +$1.3K |
|
130
Gilead Sciences
GILD
$140B
| $215K | 0.05% |
2,935
| – | – |
|
131
Palo Alto Networks
PANW
$128B
| $213K | 0.05% |
+1,500
| New | +$213K |
|
132
Qualcomm
QCOM
$170B
| $212K | 0.05% |
1,250
-250
| -17% | -$42.3K |
|
133
Autodesk
ADSK
$67.6B
| $208K | 0.05% |
+800
| New | +$208K |
|
134
Veralto
VLTO
$26.1B
| $205K | 0.05% |
+2,313
| New | +$205K |
|
135
Vanguard Total Stock Market ETF
VTI
$524B
| $204K | 0.05% |
+785
| New | +$204K |
|
136
Ford
F
$46.2B
| $167K | 0.04% |
12,600
-350
| -3% | -$4.65K |
|
137
FVCBankcorp
FVCB
$243M
| $149K | 0.03% |
12,206
| – | – |
|
138
AGNC Investment
AGNC
$10.4B
| $120K | 0.03% |
12,100
| – | – |
|
139
Warner Bros
WBD
$29.5B
| $95.8K | 0.02% |
+10,977
| New | +$95.8K |
|
140
Rani Therapeutics
RANI
$23.2M
| $61.9K | 0.01% |
19,893
| – | – |
|
141
Lineage Cell Therapeutics
LCTX
$281M
| $19.2K | ﹤0.01% |
13,000
| – | – |
|
|
142
Enovis
ENOV
$1.75B
| – | – |
-29,832
| Closed | -$1.67M |
|
143
Mondelez International
MDLZ
$79.3B
| – | – |
-2,847
| Closed | -$206K |
|
|
AIFF
144
Firefly Neuroscience, Inc. Common Stock
AIFF
$35.8M
| – | – |
-4,160
| Closed | -$21.1K |
|